CareLit · DOI-Nachweis · Aktuelle Neurologie
The effect of a combined mitoxantrone and methylprednisolone therapy in primary compared to secondary progressive multiple sclerosis – an interim analysis after five years
DOI 10.1055/s-2004-833327
Bibliografische Angaben
Nachweis in CareLit
Autor:innenVC Zingler, M Strupp, K Jahn, A Gross, R Hohlfeld, T Brandt
ZeitschriftAktuelle Neurologie
Ausgabe09/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Mitoxantrone (mitox) has been shown an effective treatment in secondary progressive (SP)- and relapsing-remitting multiple sclerosis (MS), (Hartung et al., Lancet 2002). The aim of this open trial was to evaluate the effects of a combined mitox and methylprednisolone (MP) therapy for patients with primary progressive (PP)-MS compared to SP-MS. Methods: This prospective study included patients with either…
Zitieren
Zitierempfehlung
VC Zingler, M Strupp, K Jahn, A Gross, R Hohlfeld, T Brandt (2004) The effect of a combined mitoxantrone and methylprednisolone therapy in primary compared to secondary progressive multiple sclerosis – an interim analysis after five years. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2004-833327
Mit CareLit weiterarbeiten